Shares of Cerner Co. (NASDAQ:CERN) have received a consensus recommendation of “Hold” from the twenty-six ratings firms that are covering the firm, MarketBeat reports. Seventeen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $68.25.
Several analysts have issued reports on the company. Evercore ISI assumed coverage on Cerner in a research note on Thursday, January 18th. They issued an “in-line” rating and a $77.00 target price on the stock. Jefferies Group set a $79.00 target price on Cerner and gave the company a “buy” rating in a research note on Friday, October 13th. SunTrust Banks restated a “buy” rating and issued a $75.00 target price on shares of Cerner in a research note on Monday, October 30th. Robert W. Baird restated a “buy” rating on shares of Cerner in a research note on Wednesday, January 3rd. Finally, Leerink Swann restated a “hold” rating on shares of Cerner in a research note on Saturday, November 25th.
In related news, CEO Clifford W. Illig sold 140,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the completion of the transaction, the chief executive officer now directly owns 1,229,719 shares in the company, valued at $80,571,188.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Marc G. Naughton sold 60,000 shares of the business’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $70.64, for a total value of $4,238,400.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 788,000 shares of company stock valued at $52,190,800. 13.11% of the stock is owned by company insiders.
Shares of Cerner (NASDAQ CERN) opened at $69.13 on Tuesday. The stock has a market capitalization of $22,980.00, a price-to-earnings ratio of 34.39, a price-to-earnings-growth ratio of 2.05 and a beta of 0.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75. Cerner has a one year low of $50.33 and a one year high of $73.86.
Cerner (NASDAQ:CERN) last issued its earnings results on Thursday, October 26th. The company reported $0.61 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.01). The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.59 earnings per share. equities research analysts predict that Cerner will post 2.24 EPS for the current year.
TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/23/cerner-co-cern-receives-average-recommendation-of-hold-from-analysts.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.